Chart 3.
Recommendations | Class | Level of evidence |
---|---|---|
Symptomatic patients with paroxysmal AF refractory or intolerant to at least one class I/III AA drug when rhythm control is the strategy of choice | I | A |
Symptomatic patients with AF refractory or intolerant to at least one class I or III antiarrhythmic drug | IIa | A |
As first therapy in patients with symptomatic, recurrent AF (before AA drugs), if this is the patient’s preference | IIa | B |
Symptomatic patients with long-standing persistent AF (>12 months), refractory or intolerant to at least one class I or III AA drug when rhythm control is the strategy of choice | IIb | B |
As first therapy (before class I or III AA drug) in patients with persistent AF when rhythm control is the strategy of choice | IIb | C |
Patients that cannot be treated with anticoagulants during or after the catheter ablation procedure | III | C |
AF: atrial fibrillation; AA: antiarrhythmic